U.S. Intrauterine Devices Market Size, By Product (Copper IUD, Hormonal IUD), By Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+), Industry Analysis Report, Zonal Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032

U.S. Intrauterine Devices Market Size, By Product (Copper IUD, Hormonal IUD), By Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+), Industry Analysis Report, Zonal Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032

U.S. Intrauterine Devices Market is estimated to grow during 2023–2032 owing to an increasing awareness regarding the use of such devices, especially among the American female population. Implementation of such devices for birth control offers enhanced patient compliance, ease of use, and low maintenance, while increasing the rate of effective contraception.

Smaller frameless copper and levonorgestrel-releasing devices, along with recent innovations in intrauterine technology, may contribute to a rise in the usage of IUDs among teenagers and nulliparous women. Besides, several government and non-government organizations in the republic are also working on spreading awareness regarding the significance of contraceptive products, including IUDs, thus propelling the business revenue.

Overall, the U.S. intrauterine devices industry is segmented in terms of product, age group, and zone.

Based on the product, the copper IUD segment will exhibit considerable growth during 2032. A thin copper wire used in Copper's IUD loops around the tstem. The IUD prevents conception for a period of ten years, proving to be more than 99% effective at preventing pregnancy, thus increasing its penetration in the years to come.

Considering the age, the 20–24 age group segment is anticipated to depict over 9.5% CAGR between 2023–2022. Increasing adoption of IUDs among adult women owing to planned delayed pregnancies will assist the segmental growth over the next 10 years. In addition, variables such as preventing pregnancy for a long time, increasing the availability of safe & effective intrauterine devices, and decreasing the chances of ectopic pregnancy will most likely accelerate the product adoption rate among this age group during the estimated timeframe.

Considering the zone, the Northeast U.S. intrauterine devices market will register strong gains during 2023-2032. A mounting number of unintended pregnancies and related health consequences coupled with the rising preference for highly effective contraceptive options in the zone will impel the business expansion.

Moreover, the increasing rate of hospitalization owing to the high incidences of abortion and supportive healthcare policies in the zone will also favor the industry outlook. According to the Guttmacher Institute projections, approximately 48,830 abortions took place in New Jersey in 2020. Moreover, several awareness initiatives taken by the central government for young adults concerning intrauterine devices and sexual health would further thrive the market growth substantially.